New Strong Buy Stocks for February 23rd
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Okeanis Eco Tankers Corp. ECO: This shipping company has seen the Zacks Consensus Estimate for its current year earnings increasing 74% over the last 60 days.
Okeanis Eco Tankers Corp. Price and Consensus
Okeanis Eco Tankers Corp. price-consensus-chart | Okeanis Eco Tankers Corp. Quote
Bank of Hawaii Corporation BOH: This bank holding company for Bank of Hawaii has seen the Zacks Consensus Estimate for its current year earnings increasing 10.7% over the last 60 days.
Bank of Hawaii Corporation Price and Consensus
Bank of Hawaii Corporation price-consensus-chart | Bank of Hawaii Corporation Quote
Constellium SE CSTM: This aluminum manufacturing company has seen the Zacks Consensus Estimate for its current year earnings increasing 20.6% over the last 60 days.
Constellium SE Price and Consensus
Constellium SE price-consensus-chart | Constellium SE Quote
Nicolet Bankshares, Inc. NIC: This bank holding company for Nicolet National Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 20.3% over the last 60 days.
Nicolet Bankshares Inc. Price and Consensus
Nicolet Bankshares Inc. price-consensus-chart | Nicolet Bankshares Inc. Quote
Digital Turbine, Inc. APPS: This mobile marketing platform company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.1% over the last 60 days.
Digital Turbine, Inc. Price and Consensus
Digital Turbine, Inc. price-consensus-chart | Digital Turbine, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Is Dogecoin (DOGE) Era Over? 19K Investors are Watching Mutuum Finance (MUTM)

Two charged in Australia over $5 million crypto fraud
Merck to create separate cancer business to offset Keytruda patent loss, WSJ reports
